Merck Scores As Judge Spurns New Fosamax Class
Despite months of plaintiffs' lobbying, the federal judge overseeing the Fosamax product liability litigation against pharmaceutical giant Merck & Co. has declined to grant class status to patients who have not...To view the full article, register now.
Already a subscriber? Click here to view full article